These agonists are strong inducers of the CYP1A1 enzyme [15], and we found that tranilast increases CYP1A1 expression in breast cancer cells (Fig. 6A) by EROD enzymatic assay [26] in vitro. The gene discussed is CYP1A1; the disease is breast cancer.